Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q3 2022
Institutional positions in Cidara Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −4 vs. Q2 2022
- Shares held
- 27.1M
- −142.6K (−0.5%) vs. Q2 2022
- Total value
- $17.1M
- +$3.77M (+28.3%) vs. Q2 2022
- New holders
- 5
- 11 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 243 | $0 | 0.00% | +33+15.7% | Added |
| Wells Fargo & Company | 409 | $0 | 0.00% | +12+3.0% | Added |
| Group One Trading, L.P. | 405 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 353 | $222 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 8,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Stratos Wealth Partners, LTD. | 10,489 | $7.00K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 11,672 | $7.00K | 0.00% | +11,672 | New |
| Tower Research Capital LLC (TRC) | 12,823 | $8.00K | 0.00% | −9,404−42.3% | Reduced |
| Fisher Asset Management, LLC | 16,500 | $10.0K | 0.00% | −2,300−12.2% | Reduced |
| Russell Investments Group, Ltd. | 17,100 | $10.0K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 17,001 | $11.0K | 0.00% | −18,258−51.8% | Reduced |
| Virtu Financial LLC | 20,889 | $13.0K | 0.00% | −4,997−19.3% | Reduced |
| Advisor Group Holdings, Inc. | 22,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 28,200 | $18.0K | 0.00% | −10,494−27.1% | Reduced |
| Two Sigma Securities, LLC | 41,819 | $26.0K | 0.00% | +41,819 | New |
| Aveo Capital Partners, LLC | 42,502 | $27.0K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 54,000 | $34.0K | 0.00% | +54,000 | New |
| Goldman Sachs Group Inc | 72,391 | $45.0K | 0.00% | −6,171−7.9% | Reduced |
| Millennium Management LLC | 83,716 | $53.0K | 0.00% | +32,062+62.1% | Added |
| Raymond James Financial Services Advisors, Inc. | 88,686 | $56.0K | 0.00% | +1,947+2.2% | Added |
| Tocqueville Asset Management L.P. | 104,000 | $65.0K | 0.00% | +104,000 | New |
| Northern Trust Corp | 105,490 | $66.0K | 0.00% | +7,097+7.2% | Added |
| Bridgeway Capital Management, LLC | 140,000 | $88.0K | 0.00% | −100,000−41.7% | Reduced |
| Jeppson Wealth Management, LLC | 174,175 | $109.0K | 0.05% | −6,900−3.8% | Reduced |
| BlackRock Inc. | 196,609 | $124.0K | 0.00% | −36,579−15.7% | Reduced |
| Artal Group S.A. | 224,675 | $141.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 230,937 | $145.0K | 0.00% | +54,700+31.0% | Added |
| US Bancorp | 262,072 | $165.0K | 0.00% | 00.0% | Unchanged |
| West Family Investments, Inc. | 368,910 | $232.0K | 0.10% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 369,099 | $232.0K | 0.09% | +369,099 | New |
| Geode Capital Management, LLC | 584,981 | $367.0K | 0.00% | +82,932+16.5% | Added |
| Knott David M Jr | 686,027 | $431.0K | 0.20% | +50,773+8.0% | Added |
| 5AM Venture Management, LLC | 1,134,511 | $712.0K | 0.14% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,213,531 | $760.0K | 0.00% | +98,694+8.9% | Added |
| Renaissance Technologies LLC | 1,293,273 | $812.0K | 0.00% | +137,016+11.8% | Added |
| Alethea Capital Management, LLC | 1,677,194 | $1.05M | 1.33% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,467,933 | $1.55M | 0.00% | +6,300+0.3% | Added |
| Point72 Asset Management, L.P. | 3,868,006 | $2.43M | 0.01% | −331,994−7.9% | Reduced |
| Nantahala Capital Management, LLC | 4,559,201 | $2.92M | 0.29% | −259,889−5.4% | Reduced |
| BVF Inc | 6,861,127 | $4.31M | 0.18% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −208,443−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −57,350−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −44,185−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,625−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −25,157−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −11,397−100.0% | Sold out |
| Shufro Rose & Co LLC | 0 | $0 | 0.00% | −10,413−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,208−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |